AKT1 and cancer: As key intermediates in oncogenic EGFR, MAPK, RAS/RAF/MEK/ERK and PI3K/AKT/mTOR signaling, FAM83 involved in a variety of important cancer cell signaling functions and overexpressed in many human cancers [9,10,21–24].